Selected research
Industry Growth & Trends
Global Sustained-release Medicine Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Sustained-release Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Sustained-release Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Sustained-release Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sustained-release Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Sustained-release Medicine market include Zhuhai Rundu Pharmaceutical, Endo Pharmaceuticals, Takeda, Shanghai Shyndec Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Pfizer and China Res Double-Crane, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Sustained-release Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sustained-release Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sustained-release Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sustained-release Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Sustained-release Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sustained-release Medicine Market by Company
Zhuhai Rundu Pharmaceutical
Endo Pharmaceuticals
Takeda
Shanghai Shyndec Pharmaceutical
Sanofi
Johnson & Johnson
Novartis
Pfizer
China Res Double-Crane
Bayer
AbbVie
AstraZeneca
Collegium Pharmaceutical, Inc
Sustained-release Medicine Segment by Type
Original Ground Medicine
Generic Medicine
Sustained-release Medicine Segment by Application
Hospital
Drugstore
Other
Sustained-release Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sustained-release Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sustained-release Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sustained-release Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Sustained-release Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Original Ground Medicine
- Generic Medicine
Applications
- Hospital
- Drugstore
- Other
Companies covered
- Zhuhai Rundu Pharmaceutical
- Endo Pharmaceuticals
- Takeda
- Shanghai Shyndec Pharmaceutical
- Sanofi
- Johnson & Johnson
- Novartis
- Pfizer
- China Res Double-Crane
- Bayer
- AbbVie
- AstraZeneca
- Collegium Pharmaceutical, Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Sustained-release Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Sustained-release Medicine Market Size by Region (2021-2032)
- 1.4.1 Global Sustained-release Medicine Market Size by Region (2021-2026)
- 1.4.2 Global Sustained-release Medicine Market Size by Region (2027-2032)
- 1.5 Key Regions Sustained-release Medicine Market Size (2021-2032)
- 1.5.1 North America Sustained-release Medicine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Sustained-release Medicine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Sustained-release Medicine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Sustained-release Medicine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Sustained-release Medicine Market Size Growth Rate (2021-2032)
2 Sustained-release Medicine Market by Type
- 2.1 Type Introduction
- 2.1.1 Original Ground Medicine
- 2.1.2 Generic Medicine
- 2.2 Global Sustained-release Medicine Market Size by Type
- 2.2.1 Global Sustained-release Medicine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Sustained-release Medicine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Sustained-release Medicine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Sustained-release Medicine Market Size by Regions
- 2.3.1 North America Sustained-release Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Sustained-release Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Sustained-release Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Sustained-release Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Sustained-release Medicine Market Size Breakdown by Type (2021-2026)
3 Sustained-release Medicine Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Drugstore
- 3.1.3 Other
- 3.2 Global Sustained-release Medicine Market Size by Application
- 3.2.1 Global Sustained-release Medicine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Sustained-release Medicine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Sustained-release Medicine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Sustained-release Medicine Market Size by Regions
- 3.3.1 North America Sustained-release Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Sustained-release Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Sustained-release Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Sustained-release Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Sustained-release Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Sustained-release Medicine Industry Trends
- 4.2 Sustained-release Medicine Industry Drivers
- 4.3 Sustained-release Medicine Industry Opportunities and Challenges
- 4.4 Sustained-release Medicine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Sustained-release Medicine Revenue (2021-2026)
- 5.2 Global Sustained-release Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Sustained-release Medicine Key Company Headquarters & Area Served
- 5.4 Global Sustained-release Medicine Company, Product Type & Application
- 5.5 Global Sustained-release Medicine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Sustained-release Medicine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Sustained-release Medicine Players Market Share by Revenue in 2025
- 5.6.3 2025 Sustained-release Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Zhuhai Rundu Pharmaceutical
- 6.1.1 Zhuhai Rundu Pharmaceutical Company Information
- 6.1.2 Zhuhai Rundu Pharmaceutical Business Overview
- 6.1.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Portfolio
- 6.1.5 Zhuhai Rundu Pharmaceutical Recent Developments
- 6.2 Endo Pharmaceuticals
- 6.2.1 Endo Pharmaceuticals Company Information
- 6.2.2 Endo Pharmaceuticals Business Overview
- 6.2.3 Endo Pharmaceuticals Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Endo Pharmaceuticals Sustained-release Medicine Product Portfolio
- 6.2.5 Endo Pharmaceuticals Recent Developments
- 6.3 Takeda
- 6.3.1 Takeda Company Information
- 6.3.2 Takeda Business Overview
- 6.3.3 Takeda Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Takeda Sustained-release Medicine Product Portfolio
- 6.3.5 Takeda Recent Developments
- 6.4 Shanghai Shyndec Pharmaceutical
- 6.4.1 Shanghai Shyndec Pharmaceutical Company Information
- 6.4.2 Shanghai Shyndec Pharmaceutical Business Overview
- 6.4.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Portfolio
- 6.4.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 6.5 Sanofi
- 6.5.1 Sanofi Company Information
- 6.5.2 Sanofi Business Overview
- 6.5.3 Sanofi Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Sanofi Sustained-release Medicine Product Portfolio
- 6.5.5 Sanofi Recent Developments
- 6.6 Johnson & Johnson
- 6.6.1 Johnson & Johnson Company Information
- 6.6.2 Johnson & Johnson Business Overview
- 6.6.3 Johnson & Johnson Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Johnson & Johnson Sustained-release Medicine Product Portfolio
- 6.6.5 Johnson & Johnson Recent Developments
- 6.7 Novartis
- 6.7.1 Novartis Company Information
- 6.7.2 Novartis Business Overview
- 6.7.3 Novartis Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Novartis Sustained-release Medicine Product Portfolio
- 6.7.5 Novartis Recent Developments
- 6.8 Pfizer
- 6.8.1 Pfizer Company Information
- 6.8.2 Pfizer Business Overview
- 6.8.3 Pfizer Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Pfizer Sustained-release Medicine Product Portfolio
- 6.8.5 Pfizer Recent Developments
- 6.9 China Res Double-Crane
- 6.9.1 China Res Double-Crane Company Information
- 6.9.2 China Res Double-Crane Business Overview
- 6.9.3 China Res Double-Crane Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 China Res Double-Crane Sustained-release Medicine Product Portfolio
- 6.9.5 China Res Double-Crane Recent Developments
- 6.10 Bayer
- 6.10.1 Bayer Company Information
- 6.10.2 Bayer Business Overview
- 6.10.3 Bayer Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Bayer Sustained-release Medicine Product Portfolio
- 6.10.5 Bayer Recent Developments
- 6.11 AbbVie
- 6.11.1 AbbVie Company Information
- 6.11.2 AbbVie Business Overview
- 6.11.3 AbbVie Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 AbbVie Sustained-release Medicine Product Portfolio
- 6.11.5 AbbVie Recent Developments
- 6.12 AstraZeneca
- 6.12.1 AstraZeneca Company Information
- 6.12.2 AstraZeneca Business Overview
- 6.12.3 AstraZeneca Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 AstraZeneca Sustained-release Medicine Product Portfolio
- 6.12.5 AstraZeneca Recent Developments
- 6.13 Collegium Pharmaceutical, Inc
- 6.13.1 Collegium Pharmaceutical, Inc Company Information
- 6.13.2 Collegium Pharmaceutical, Inc Business Overview
- 6.13.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Collegium Pharmaceutical, Inc Sustained-release Medicine Product Portfolio
- 6.13.5 Collegium Pharmaceutical, Inc Recent Developments
7 North America
- 7.1 North America Sustained-release Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Sustained-release Medicine Market Size by Country (2021-2026)
- 7.3 North America Sustained-release Medicine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Sustained-release Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Sustained-release Medicine Market Size by Country (2021-2026)
- 8.3 Europe Sustained-release Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Sustained-release Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Sustained-release Medicine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Sustained-release Medicine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Sustained-release Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Sustained-release Medicine Market Size by Country (2021-2026)
- 10.3 South America Sustained-release Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Sustained-release Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Sustained-release Medicine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Sustained-release Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst